TriangleNCT00051311 · OUTCOME
Median Time to Neutrophil Recovery
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- Days
- Interval / dispersion
- Full Range
- Time frame
- Up to 2 months after stem cell transplant
What was measured
Neutrophil recovery is defined as a neutrophil count ≥5000 µl for three consecutive days.
Analysis population: The time to neutrophil recovery could not be determined precisely for 1 recipient who received granulocyte transfusions for an active infection following transplantation.
Groups in this outcome
Recipient
Recipients will receive induction chemotherapy with fludarabine, cyclophosphamide, etoposide, doxorubicin, vincristine, and prednisone. (one cycle is 5 days on drug therapy followed by a 16 day rest period). Prior to the transplant procedure, recipients will receive conditioning therapy followed by the infusion of donor stem cells. Methotrexate: Recipients will receive 4 doses of methotrexate by vein after the transplant to help prevent graft-versus-host disease (GVHD). Cyclosporine: Recipients will receive cyclosporine by vein or by mouth for about 6 months after the transplant to help prevent graft-versus-host disease (GVHD).
| Group | Source count |
|---|---|
| Recipient | 30 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Recipient | 14 | Not reported | 7 | 21 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 7
- upper Limit
- 21
- value
- 14
- denoms
- counts
- group Id
- OG000
- value
- 30
- units
- Participants
- description
- Neutrophil recovery is defined as a neutrophil count ≥5000 µl for three consecutive days.
- dispersion Type
- Full Range
- groups
- description
- Recipients will receive induction chemotherapy with fludarabine, cyclophosphamide, etoposide, doxorubicin, vincristine, and prednisone. (one cycle is 5 days on drug therapy followed by a 16 day rest period). Prior to the transplant procedure, recipients will receive conditioning therapy followed by the infusion of donor stem cells. Methotrexate: Recipients will receive 4 doses of methotrexate by vein after the transplant to help prevent graft-versus-host disease (GVHD). Cyclosporine: Recipients will receive cyclosporine by vein or by mouth for about 6 months after the transplant to help prevent graft-versus-host disease (GVHD).
- id
- OG000
- title
- Recipient
- param Type
- MEDIAN
- population Description
- The time to neutrophil recovery could not be determined precisely for 1 recipient who received granulocyte transfusions for an active infection following transplantation.
- reporting Status
- POSTED
- time Frame
- Up to 2 months after stem cell transplant
- title
- Median Time to Neutrophil Recovery
- type
- SECONDARY
- unit Of Measure
- Days
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice